Cue Biopharma
45 hedge funds and large institutions have $51.3M invested in Cue Biopharma in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.27% more ownership
Funds ownership: 21.66% → 26.93% (+5.3%)
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.5M | |
| 2 | +$2.53M | |
| 3 | +$1.21M | |
| 4 |
BlackRock
New York
|
+$617K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$574K |
Top Sellers
| 1 | -$221K | |
| 2 | -$119K | |
| 3 | -$64.3K | |
| 4 |
RCG
Rock Creek Group
Washington,
District of Columbia
|
-$60.6K |
| 5 |
Citigroup
New York
|
-$21.7K |